Daily news on healthcare and wellness in Italy

Provided by AGP

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
3 hours ago

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute

GlobeNewswire, Inc.

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
4 hours ago

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy

GlobeNewswire, Inc.

VCD Medical Appoints Renowned Commercial and Vascular Leader  Denna Babul as General Manager, U.S.
3 hours ago

VCD Medical Appoints Renowned Commercial and Vascular Leader Denna Babul as General Manager, U.S.

GlobeNewswire, Inc.

Beyond the Base: Soccer Match Unites NSA Naples, Italian Community
6 hours ago

Beyond the Base: Soccer Match Unites NSA Naples, Italian Community

DVIDS - Georgia

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
5 hours ago

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

GlobeNewswire, Inc.

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
9 hours ago

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

GlobeNewswire, Inc.

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
10 hours ago

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

GlobeNewswire, Inc.

Senegal, US and allied medical teams conclude multinational medical readiness exercise during African Lion 26
May. 6, 2026

Senegal, US and allied medical teams conclude multinational medical readiness exercise during African Lion 26

DVIDS - Georgia

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
May. 6, 2026

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

GlobeNewswire, Inc.

[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research
May. 6, 2026

[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research

GlobeNewswire, Inc.

Bruno Vision Care’s Deseyne® Wins 2026 MedTech Breakthrough Award
2 hours ago

Bruno Vision Care’s Deseyne® Wins 2026 MedTech Breakthrough Award

GlobeNewswire, Inc.

Epredia E1000 Dx™ Digital Pathology Solution Named “Best New Diagnostic Technology Solution” in 2026 MedTech Breakthrough Awards Program
2 hours ago

Epredia E1000 Dx™ Digital Pathology Solution Named “Best New Diagnostic Technology Solution” in 2026 MedTech Breakthrough Awards Program

GlobeNewswire, Inc.

US, Senegal multinational medical teams strengthen readiness through ingenuity
May. 5, 2026

US, Senegal multinational medical teams strengthen readiness through ingenuity

DVIDS - Georgia

[Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns
May. 5, 2026

[Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns

GlobeNewswire, Inc.

U.S. Naval Hospital Naples Earns Top Defense Health Agency Award for High Reliability Excellence
May. 5, 2026

U.S. Naval Hospital Naples Earns Top Defense Health Agency Award for High Reliability Excellence

DVIDS - Georgia

Global Environmental Health and Safety Software Market Size/Share Worth USD 14.52 Billion by 2035 at a 7.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
May. 5, 2026

Global Environmental Health and Safety Software Market Size/Share Worth USD 14.52 Billion by 2035 at a 7.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

GlobeNewswire, Inc.

[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
May. 4, 2026

[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire, Inc.

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
May. 4, 2026

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

GlobeNewswire, Inc.

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
May. 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

GlobeNewswire, Inc.

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
May. 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

GlobeNewswire, Inc.

Sign up for:

Health Watch Italy

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share us

on your social networks: